CA2544373A1 - Blood test prototypes and methods for the detection of circulating tumor and endothelial cells - Google Patents
Blood test prototypes and methods for the detection of circulating tumor and endothelial cells Download PDFInfo
- Publication number
- CA2544373A1 CA2544373A1 CA002544373A CA2544373A CA2544373A1 CA 2544373 A1 CA2544373 A1 CA 2544373A1 CA 002544373 A CA002544373 A CA 002544373A CA 2544373 A CA2544373 A CA 2544373A CA 2544373 A1 CA2544373 A1 CA 2544373A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- cell
- blood
- cell adhesion
- cam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000004881 tumor cell Anatomy 0.000 title claims abstract description 154
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 152
- 238000000034 method Methods 0.000 title claims abstract description 93
- 238000001514 detection method Methods 0.000 title claims abstract description 50
- 210000002889 endothelial cell Anatomy 0.000 title claims abstract description 26
- 238000009534 blood test Methods 0.000 title abstract description 8
- 210000004027 cell Anatomy 0.000 claims abstract description 379
- 239000008280 blood Substances 0.000 claims abstract description 149
- 210000004369 blood Anatomy 0.000 claims abstract description 141
- 201000011510 cancer Diseases 0.000 claims abstract description 72
- 239000011159 matrix material Substances 0.000 claims abstract description 50
- 230000021164 cell adhesion Effects 0.000 claims abstract description 39
- 230000003511 endothelial effect Effects 0.000 claims abstract description 31
- 239000012530 fluid Substances 0.000 claims abstract description 22
- 206010061289 metastatic neoplasm Diseases 0.000 claims abstract description 20
- 210000000130 stem cell Anatomy 0.000 claims abstract description 20
- 201000010099 disease Diseases 0.000 claims abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 18
- 230000001605 fetal effect Effects 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 238000003793 prenatal diagnosis Methods 0.000 claims abstract description 6
- 210000001672 ovary Anatomy 0.000 claims description 59
- 108090000623 proteins and genes Proteins 0.000 claims description 53
- 229920001436 collagen Polymers 0.000 claims description 30
- 102000008186 Collagen Human genes 0.000 claims description 24
- 108010035532 Collagen Proteins 0.000 claims description 24
- 238000001914 filtration Methods 0.000 claims description 22
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 17
- 238000000684 flow cytometry Methods 0.000 claims description 17
- 229920000669 heparin Polymers 0.000 claims description 17
- 229960002897 heparin Drugs 0.000 claims description 17
- 238000000926 separation method Methods 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- 239000011324 bead Substances 0.000 claims description 13
- 239000011162 core material Substances 0.000 claims description 11
- 239000003446 ligand Substances 0.000 claims description 11
- 239000011325 microbead Substances 0.000 claims description 11
- 238000003753 real-time PCR Methods 0.000 claims description 11
- 102100023832 Prolyl endopeptidase FAP Human genes 0.000 claims description 10
- 238000004458 analytical method Methods 0.000 claims description 10
- -1 bone Substances 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 10
- 210000001519 tissue Anatomy 0.000 claims description 10
- 206010003445 Ascites Diseases 0.000 claims description 9
- 230000002068 genetic effect Effects 0.000 claims description 9
- 238000000018 DNA microarray Methods 0.000 claims description 8
- 101100368708 Homo sapiens TACSTD2 gene Proteins 0.000 claims description 8
- 102100027212 Tumor-associated calcium signal transducer 2 Human genes 0.000 claims description 8
- 108010072257 fibroblast activation protein alpha Proteins 0.000 claims description 8
- 239000003550 marker Substances 0.000 claims description 8
- 102000016289 Cell Adhesion Molecules Human genes 0.000 claims description 7
- 108010067225 Cell Adhesion Molecules Proteins 0.000 claims description 7
- 108010067306 Fibronectins Proteins 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 238000000432 density-gradient centrifugation Methods 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 238000003365 immunocytochemistry Methods 0.000 claims description 7
- 108010044426 integrins Proteins 0.000 claims description 7
- 102000006495 integrins Human genes 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 7
- 239000011521 glass Substances 0.000 claims description 6
- 230000007246 mechanism Effects 0.000 claims description 5
- 102000039446 nucleic acids Human genes 0.000 claims description 5
- 108020004707 nucleic acids Proteins 0.000 claims description 5
- 150000007523 nucleic acids Chemical class 0.000 claims description 5
- 238000011045 prefiltration Methods 0.000 claims description 5
- 238000010186 staining Methods 0.000 claims description 5
- 108010073385 Fibrin Proteins 0.000 claims description 4
- 102000009123 Fibrin Human genes 0.000 claims description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 4
- 108010031318 Vitronectin Proteins 0.000 claims description 4
- 102100035140 Vitronectin Human genes 0.000 claims description 4
- 239000000980 acid dye Substances 0.000 claims description 4
- 210000000481 breast Anatomy 0.000 claims description 4
- 229950003499 fibrin Drugs 0.000 claims description 4
- 239000007850 fluorescent dye Substances 0.000 claims description 4
- 208000037819 metastatic cancer Diseases 0.000 claims description 4
- 208000011575 metastatic malignant neoplasm Diseases 0.000 claims description 4
- 102100031940 Epithelial cell adhesion molecule Human genes 0.000 claims description 3
- 101000920667 Homo sapiens Epithelial cell adhesion molecule Proteins 0.000 claims description 3
- 101000990912 Homo sapiens Matrilysin Proteins 0.000 claims description 3
- 108010008125 Tenascin Proteins 0.000 claims description 3
- 102000007000 Tenascin Human genes 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 238000000338 in vitro Methods 0.000 claims description 3
- 239000010410 layer Substances 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 238000011002 quantification Methods 0.000 claims description 3
- 229920002307 Dextran Polymers 0.000 claims description 2
- 201000010374 Down Syndrome Diseases 0.000 claims description 2
- 108010066327 Keratin-18 Proteins 0.000 claims description 2
- 108010051335 Lipocalin-2 Proteins 0.000 claims description 2
- 208000001826 Marfan syndrome Diseases 0.000 claims description 2
- 102100030417 Matrilysin Human genes 0.000 claims description 2
- 108010008707 Mucin-1 Proteins 0.000 claims description 2
- 108010067787 Proteoglycans Proteins 0.000 claims description 2
- 102000016611 Proteoglycans Human genes 0.000 claims description 2
- 208000022292 Tay-Sachs disease Diseases 0.000 claims description 2
- 206010044688 Trisomy 21 Diseases 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims description 2
- 210000000496 pancreas Anatomy 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 claims description 2
- 210000001685 thyroid gland Anatomy 0.000 claims description 2
- 206010008805 Chromosomal abnormalities Diseases 0.000 claims 2
- 208000031404 Chromosome Aberrations Diseases 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 1
- 102000016359 Fibronectins Human genes 0.000 claims 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims 1
- 102000018329 Keratin-18 Human genes 0.000 claims 1
- 102000013519 Lipocalin-2 Human genes 0.000 claims 1
- 102000007298 Mucin-1 Human genes 0.000 claims 1
- 238000001574 biopsy Methods 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 230000006037 cell lysis Effects 0.000 claims 1
- 210000003679 cervix uteri Anatomy 0.000 claims 1
- 239000011247 coating layer Substances 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 210000003238 esophagus Anatomy 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 210000000664 rectum Anatomy 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 210000004291 uterus Anatomy 0.000 claims 1
- 230000000007 visual effect Effects 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 21
- 230000001394 metastastic effect Effects 0.000 abstract description 11
- 230000001225 therapeutic effect Effects 0.000 abstract description 11
- 238000011160 research Methods 0.000 abstract description 10
- 230000007236 host immunity Effects 0.000 abstract description 9
- 238000007479 molecular analysis Methods 0.000 abstract description 8
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 7
- 208000022471 Fetal disease Diseases 0.000 abstract 2
- 230000003169 placental effect Effects 0.000 abstract 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 76
- 210000000265 leukocyte Anatomy 0.000 description 31
- 239000000523 sample Substances 0.000 description 30
- 238000002955 isolation Methods 0.000 description 28
- 241000282414 Homo sapiens Species 0.000 description 27
- 239000000427 antigen Substances 0.000 description 22
- 102000036639 antigens Human genes 0.000 description 22
- 108091007433 antigens Proteins 0.000 description 22
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 19
- 238000003556 assay Methods 0.000 description 19
- 230000014509 gene expression Effects 0.000 description 19
- 102000005962 receptors Human genes 0.000 description 19
- 108020003175 receptors Proteins 0.000 description 19
- 210000000601 blood cell Anatomy 0.000 description 18
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 17
- 235000018102 proteins Nutrition 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 17
- 238000003745 diagnosis Methods 0.000 description 16
- 239000002609 medium Substances 0.000 description 14
- 108700012813 7-aminoactinomycin D Proteins 0.000 description 13
- 206010006187 Breast cancer Diseases 0.000 description 13
- 208000026310 Breast neoplasm Diseases 0.000 description 13
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 13
- 102000029816 Collagenase Human genes 0.000 description 12
- 108060005980 Collagenase Proteins 0.000 description 12
- 206010009944 Colon cancer Diseases 0.000 description 12
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical group [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 12
- 229910052744 lithium Inorganic materials 0.000 description 12
- 238000000386 microscopy Methods 0.000 description 12
- 210000001185 bone marrow Anatomy 0.000 description 11
- 210000004700 fetal blood Anatomy 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 11
- 210000004698 lymphocyte Anatomy 0.000 description 11
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 description 10
- 108010004729 Phycoerythrin Proteins 0.000 description 10
- 238000005119 centrifugation Methods 0.000 description 10
- 229960002424 collagenase Drugs 0.000 description 10
- 201000001441 melanoma Diseases 0.000 description 10
- 210000005259 peripheral blood Anatomy 0.000 description 10
- 239000011886 peripheral blood Substances 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 102000035195 Peptidases Human genes 0.000 description 9
- 108091005804 Peptidases Proteins 0.000 description 9
- 239000003146 anticoagulant agent Substances 0.000 description 9
- 229940127219 anticoagulant drug Drugs 0.000 description 9
- 230000004087 circulation Effects 0.000 description 9
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 9
- 210000004379 membrane Anatomy 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 9
- 201000009030 Carcinoma Diseases 0.000 description 8
- 206010027476 Metastases Diseases 0.000 description 8
- 208000003788 Neoplasm Micrometastasis Diseases 0.000 description 8
- 239000004365 Protease Substances 0.000 description 8
- 238000010240 RT-PCR analysis Methods 0.000 description 8
- 239000000834 fixative Substances 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 102100034256 Mucin-1 Human genes 0.000 description 7
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 7
- 102100038358 Prostate-specific antigen Human genes 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 239000012888 bovine serum Substances 0.000 description 7
- 238000012512 characterization method Methods 0.000 description 7
- 231100000433 cytotoxic Toxicity 0.000 description 7
- 230000001472 cytotoxic effect Effects 0.000 description 7
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000002372 labelling Methods 0.000 description 7
- 210000005087 mononuclear cell Anatomy 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 108010022452 Collagen Type I Proteins 0.000 description 6
- 102000012422 Collagen Type I Human genes 0.000 description 6
- 102000001301 EGF receptor Human genes 0.000 description 6
- 108060006698 EGF receptor Proteins 0.000 description 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 6
- 102100037362 Fibronectin Human genes 0.000 description 6
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 6
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 6
- 206010061535 Ovarian neoplasm Diseases 0.000 description 6
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 238000007726 management method Methods 0.000 description 6
- 230000009401 metastasis Effects 0.000 description 6
- 230000002611 ovarian Effects 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 5
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 5
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 5
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 5
- 108010085895 Laminin Proteins 0.000 description 5
- 102000007547 Laminin Human genes 0.000 description 5
- 229930040373 Paraformaldehyde Natural products 0.000 description 5
- 238000011529 RT qPCR Methods 0.000 description 5
- 230000001640 apoptogenic effect Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 230000004154 complement system Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 238000002493 microarray Methods 0.000 description 5
- 229920002866 paraformaldehyde Polymers 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 235000019419 proteases Nutrition 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 230000035899 viability Effects 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 4
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 4
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 108010063954 Mucins Proteins 0.000 description 4
- 102000015728 Mucins Human genes 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 239000005090 green fluorescent protein Substances 0.000 description 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 102000020233 phosphotransferase Human genes 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 208000025421 tumor of uterus Diseases 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- 206010046766 uterine cancer Diseases 0.000 description 4
- IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 3
- 102000000905 Cadherin Human genes 0.000 description 3
- 108050007957 Cadherin Proteins 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 3
- 108091006146 Channels Proteins 0.000 description 3
- 108010058546 Cyclin D1 Proteins 0.000 description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 description 3
- 108010053770 Deoxyribonucleases Proteins 0.000 description 3
- 208000005431 Endometrioid Carcinoma Diseases 0.000 description 3
- 206010015866 Extravasation Diseases 0.000 description 3
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 3
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 3
- 101000875067 Homo sapiens Collagen alpha-2(I) chain Proteins 0.000 description 3
- 101000934372 Homo sapiens Macrosialin Proteins 0.000 description 3
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 3
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 3
- 102100032700 Keratin, type I cytoskeletal 20 Human genes 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 102100025354 Macrophage mannose receptor 1 Human genes 0.000 description 3
- 102100025136 Macrosialin Human genes 0.000 description 3
- 108010031099 Mannose Receptor Proteins 0.000 description 3
- 102100035405 Neutrophil gelatinase-associated lipocalin Human genes 0.000 description 3
- 206010060862 Prostate cancer Diseases 0.000 description 3
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000033115 angiogenesis Effects 0.000 description 3
- 230000005809 anti-tumor immunity Effects 0.000 description 3
- 238000010322 bone marrow transplantation Methods 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 235000011148 calcium chloride Nutrition 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 238000003320 cell separation method Methods 0.000 description 3
- 230000000973 chemotherapeutic effect Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 201000003908 endometrial adenocarcinoma Diseases 0.000 description 3
- 208000028730 endometrioid adenocarcinoma Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000036251 extravasation Effects 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000012997 ficoll-paque Substances 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 201000005202 lung cancer Diseases 0.000 description 3
- 208000020816 lung neoplasm Diseases 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 230000003278 mimic effect Effects 0.000 description 3
- 210000005170 neoplastic cell Anatomy 0.000 description 3
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 3
- 108091022886 phosphatidate cytidylyltransferase Proteins 0.000 description 3
- 238000004393 prognosis Methods 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000011476 stem cell transplantation Methods 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 102100040121 Allograft inflammatory factor 1 Human genes 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 102100024155 Cadherin-11 Human genes 0.000 description 2
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 2
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- 108010077544 Chromatin Proteins 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 description 2
- 108010061617 Cystatin M Proteins 0.000 description 2
- 102000012177 Cystatin M Human genes 0.000 description 2
- 108091006027 G proteins Proteins 0.000 description 2
- 102000030782 GTP binding Human genes 0.000 description 2
- 108091000058 GTP-Binding Proteins 0.000 description 2
- 101710113436 GTPase KRas Proteins 0.000 description 2
- 102100030708 GTPase KRas Human genes 0.000 description 2
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 2
- 101000994460 Homo sapiens Keratin, type I cytoskeletal 20 Proteins 0.000 description 2
- 101001023271 Homo sapiens Laminin subunit gamma-2 Proteins 0.000 description 2
- 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 description 2
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 2
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 2
- 101001023833 Homo sapiens Neutrophil gelatinase-associated lipocalin Proteins 0.000 description 2
- 101000873418 Homo sapiens P-selectin glycoprotein ligand 1 Proteins 0.000 description 2
- 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 description 2
- 101000971404 Homo sapiens Protein kinase C iota type Proteins 0.000 description 2
- 101000633605 Homo sapiens Thrombospondin-2 Proteins 0.000 description 2
- 101000788548 Homo sapiens Tubulin alpha-4A chain Proteins 0.000 description 2
- 101000934581 Homo sapiens Valacyclovir hydrolase Proteins 0.000 description 2
- 102100038356 Kallikrein-2 Human genes 0.000 description 2
- 101710176220 Kallikrein-2 Proteins 0.000 description 2
- 102100033421 Keratin, type I cytoskeletal 18 Human genes 0.000 description 2
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 2
- 108010066302 Keratin-19 Proteins 0.000 description 2
- 108010013709 Leukocyte Common Antigens Proteins 0.000 description 2
- 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 2
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 2
- 241000713333 Mouse mammary tumor virus Species 0.000 description 2
- 101100346932 Mus musculus Muc1 gene Proteins 0.000 description 2
- 108700020796 Oncogene Proteins 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
- 102100036473 Phosphoribosylformylglycinamidine synthase Human genes 0.000 description 2
- 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 description 2
- 102100033237 Pro-epidermal growth factor Human genes 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 102100021557 Protein kinase C iota type Human genes 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 102100029529 Thrombospondin-2 Human genes 0.000 description 2
- 102100025239 Tubulin alpha-4A chain Human genes 0.000 description 2
- 102100033254 Tumor suppressor ARF Human genes 0.000 description 2
- 101710200333 UDP-glucuronosyltransferase 2B7 Proteins 0.000 description 2
- 102100029819 UDP-glucuronosyltransferase 2B7 Human genes 0.000 description 2
- 102000008790 VE-cadherin Human genes 0.000 description 2
- 102100025139 Valacyclovir hydrolase Human genes 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 108050003627 Wnt Proteins 0.000 description 2
- 102000013814 Wnt Human genes 0.000 description 2
- 102100026457 Zinc finger E-box-binding homeobox 1 Human genes 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000002491 angiogenic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 108010018828 cadherin 5 Proteins 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 201000010989 colorectal carcinoma Diseases 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 210000004955 epithelial membrane Anatomy 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 238000007885 magnetic separation Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000003032 molecular docking Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 108010000953 osteoblast cadherin Proteins 0.000 description 2
- 229940092253 ovalbumin Drugs 0.000 description 2
- 208000004019 papillary adenocarcinoma Diseases 0.000 description 2
- 102000029799 phosphatidate cytidylyltransferase Human genes 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 102000016914 ras Proteins Human genes 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 208000000587 small cell lung carcinoma Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- FDFPSNISSMYYDS-UHFFFAOYSA-N 2-ethyl-N,2-dimethylheptanamide Chemical compound CCCCCC(C)(CC)C(=O)NC FDFPSNISSMYYDS-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UHFFFAOYSA-N 2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
- 101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
- 102100032534 Adenosine kinase Human genes 0.000 description 1
- 108010076278 Adenosine kinase Proteins 0.000 description 1
- 102100024394 Adipocyte enhancer-binding protein 1 Human genes 0.000 description 1
- 101710105604 Adipocyte enhancer-binding protein 1 Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 108091010877 Allograft inflammatory factor 1 Proteins 0.000 description 1
- 102100037242 Amiloride-sensitive sodium channel subunit alpha Human genes 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102100034618 Annexin A3 Human genes 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 102000004121 Annexin A5 Human genes 0.000 description 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- 101100465060 Arabidopsis thaliana PRK4 gene Proteins 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-M Arachidonate Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC([O-])=O YZXBAPSDXZZRGB-DOFZRALJSA-M 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
- 108091012583 BCL2 Proteins 0.000 description 1
- 108700020462 BRCA2 Proteins 0.000 description 1
- 102100021971 Bcl-2-interacting killer Human genes 0.000 description 1
- 102100029945 Beta-galactoside alpha-2,6-sialyltransferase 1 Human genes 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 101150008921 Brca2 gene Proteins 0.000 description 1
- 102100025399 Breast cancer type 2 susceptibility protein Human genes 0.000 description 1
- 101710117545 C protein Proteins 0.000 description 1
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 description 1
- 101150073986 C3AR1 gene Proteins 0.000 description 1
- 102100021703 C3a anaphylatoxin chemotactic receptor Human genes 0.000 description 1
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 description 1
- 108010059108 CD18 Antigens Proteins 0.000 description 1
- 108010038940 CD48 Antigen Proteins 0.000 description 1
- 102100036008 CD48 antigen Human genes 0.000 description 1
- 101100381481 Caenorhabditis elegans baz-2 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100026092 Calmegin Human genes 0.000 description 1
- 102100025473 Carcinoembryonic antigen-related cell adhesion molecule 6 Human genes 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 102100026540 Cathepsin L2 Human genes 0.000 description 1
- 101710169274 Cathepsin L2 Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 238000007808 Cell invasion assay Methods 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102100028736 Claudin-10 Human genes 0.000 description 1
- 102100038423 Claudin-3 Human genes 0.000 description 1
- 108090000599 Claudin-3 Proteins 0.000 description 1
- 102100038447 Claudin-4 Human genes 0.000 description 1
- 108090000601 Claudin-4 Proteins 0.000 description 1
- 102100026098 Claudin-7 Human genes 0.000 description 1
- 108050007296 Claudin-7 Proteins 0.000 description 1
- 241000410367 Clerodendrum thomsoniae Species 0.000 description 1
- UNPLRYRWJLTVAE-UHFFFAOYSA-N Cloperastine hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 UNPLRYRWJLTVAE-UHFFFAOYSA-N 0.000 description 1
- 102000012432 Collagen Type V Human genes 0.000 description 1
- 108010022514 Collagen Type V Proteins 0.000 description 1
- 102100031502 Collagen alpha-2(V) chain Human genes 0.000 description 1
- 102000016917 Complement C1 Human genes 0.000 description 1
- 108010028774 Complement C1 Proteins 0.000 description 1
- 102100037085 Complement C1q subcomponent subunit B Human genes 0.000 description 1
- 102000004381 Complement C2 Human genes 0.000 description 1
- 108090000955 Complement C2 Proteins 0.000 description 1
- 108010077840 Complement C3a Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102100035353 Cyclin-dependent kinase 2-associated protein 1 Human genes 0.000 description 1
- 102100025621 Cytochrome b-245 heavy chain Human genes 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 101710096438 DNA-binding protein Proteins 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 101100042651 Danio rerio six1b gene Proteins 0.000 description 1
- 102000013444 Diacylglycerol Cholinephosphotransferase Human genes 0.000 description 1
- 102100031257 Diencephalon/mesencephalon homeobox protein 1 Human genes 0.000 description 1
- 108010049959 Discoidins Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 102100023274 Dual specificity mitogen-activated protein kinase kinase 4 Human genes 0.000 description 1
- 102100035079 ETS-related transcription factor Elf-3 Human genes 0.000 description 1
- 108700037623 ETS-related transcription factor Elf-3 Proteins 0.000 description 1
- 102100021977 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Human genes 0.000 description 1
- 108050004000 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Proteins 0.000 description 1
- 108010043945 Ephrin-A1 Proteins 0.000 description 1
- 102000020086 Ephrin-A1 Human genes 0.000 description 1
- 102100038595 Estrogen receptor Human genes 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 102100031758 Extracellular matrix protein 1 Human genes 0.000 description 1
- 101710127949 Extracellular matrix protein 1 Proteins 0.000 description 1
- 102100023077 Extracellular matrix protein 2 Human genes 0.000 description 1
- 101710127932 Extracellular matrix protein 2 Proteins 0.000 description 1
- 102100021655 Extracellular sulfatase Sulf-1 Human genes 0.000 description 1
- 101710158992 FHF complex subunit HOOK interacting protein 1B Proteins 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 102100035323 Fibroblast growth factor 18 Human genes 0.000 description 1
- 102100023590 Fibroblast growth factor-binding protein 1 Human genes 0.000 description 1
- 102100038647 Fibroleukin Human genes 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 102100037858 G1/S-specific cyclin-E1 Human genes 0.000 description 1
- 206010061968 Gastric neoplasm Diseases 0.000 description 1
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
- 102100041007 Glia maturation factor gamma Human genes 0.000 description 1
- 102000051366 Glycosyltransferases Human genes 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 description 1
- 102100029966 HLA class II histocompatibility antigen, DP alpha 1 chain Human genes 0.000 description 1
- 102100036241 HLA class II histocompatibility antigen, DQ beta 1 chain Human genes 0.000 description 1
- 102100040505 HLA class II histocompatibility antigen, DR alpha chain Human genes 0.000 description 1
- 108010093061 HLA-DPA1 antigen Proteins 0.000 description 1
- 108010065026 HLA-DQB1 antigen Proteins 0.000 description 1
- 108010067802 HLA-DR alpha-Chains Proteins 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
- 102100038720 Histone deacetylase 9 Human genes 0.000 description 1
- 101710177326 Histone deacetylase 9 Proteins 0.000 description 1
- 102100023696 Histone-lysine N-methyltransferase SETDB1 Human genes 0.000 description 1
- 108700005087 Homeobox Genes Proteins 0.000 description 1
- 102100037099 Homeobox protein MOX-1 Human genes 0.000 description 1
- 102000009331 Homeodomain Proteins Human genes 0.000 description 1
- 108010048671 Homeodomain Proteins Proteins 0.000 description 1
- 101000890626 Homo sapiens Allograft inflammatory factor 1 Proteins 0.000 description 1
- 101000740448 Homo sapiens Amiloride-sensitive sodium channel subunit alpha Proteins 0.000 description 1
- 101000924454 Homo sapiens Annexin A3 Proteins 0.000 description 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
- 101000970576 Homo sapiens Bcl-2-interacting killer Proteins 0.000 description 1
- 101000863864 Homo sapiens Beta-galactoside alpha-2,6-sialyltransferase 1 Proteins 0.000 description 1
- 101000899361 Homo sapiens Bone morphogenetic protein 7 Proteins 0.000 description 1
- 101000980814 Homo sapiens CAMPATH-1 antigen Proteins 0.000 description 1
- 101000912631 Homo sapiens Calmegin Proteins 0.000 description 1
- 101000914326 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 6 Proteins 0.000 description 1
- 101000766993 Homo sapiens Claudin-10 Proteins 0.000 description 1
- 101000993285 Homo sapiens Collagen alpha-1(III) chain Proteins 0.000 description 1
- 101000941594 Homo sapiens Collagen alpha-2(V) chain Proteins 0.000 description 1
- 101000740680 Homo sapiens Complement C1q subcomponent subunit B Proteins 0.000 description 1
- 101000844735 Homo sapiens Diencephalon/mesencephalon homeobox protein 1 Proteins 0.000 description 1
- 101001115395 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 4 Proteins 0.000 description 1
- 101001010541 Homo sapiens Electron transfer flavoprotein subunit alpha, mitochondrial Proteins 0.000 description 1
- 101000882584 Homo sapiens Estrogen receptor Proteins 0.000 description 1
- 101000820630 Homo sapiens Extracellular sulfatase Sulf-1 Proteins 0.000 description 1
- 101000878128 Homo sapiens Fibroblast growth factor 18 Proteins 0.000 description 1
- 101000827725 Homo sapiens Fibroblast growth factor-binding protein 1 Proteins 0.000 description 1
- 101001031613 Homo sapiens Fibroleukin Proteins 0.000 description 1
- 101000738568 Homo sapiens G1/S-specific cyclin-E1 Proteins 0.000 description 1
- 101001039458 Homo sapiens Glia maturation factor gamma Proteins 0.000 description 1
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 description 1
- 101000684609 Homo sapiens Histone-lysine N-methyltransferase SETDB1 Proteins 0.000 description 1
- 101000955035 Homo sapiens Homeobox protein MOX-1 Proteins 0.000 description 1
- 101000975401 Homo sapiens Inositol 1,4,5-trisphosphate receptor type 3 Proteins 0.000 description 1
- 101001015064 Homo sapiens Integrin beta-6 Proteins 0.000 description 1
- 101000997670 Homo sapiens Integrin beta-8 Proteins 0.000 description 1
- 101001083151 Homo sapiens Interleukin-10 receptor subunit alpha Proteins 0.000 description 1
- 101000998020 Homo sapiens Keratin, type I cytoskeletal 18 Proteins 0.000 description 1
- 101000934774 Homo sapiens Keratin, type II cytoskeletal 6C Proteins 0.000 description 1
- 101000663639 Homo sapiens Kunitz-type protease inhibitor 2 Proteins 0.000 description 1
- 101001018097 Homo sapiens L-selectin Proteins 0.000 description 1
- 101001022948 Homo sapiens LIM domain-binding protein 2 Proteins 0.000 description 1
- 101000972486 Homo sapiens Laminin subunit alpha-3 Proteins 0.000 description 1
- 101000972488 Homo sapiens Laminin subunit alpha-4 Proteins 0.000 description 1
- 101001008527 Homo sapiens Laminin subunit alpha-5 Proteins 0.000 description 1
- 101001008568 Homo sapiens Laminin subunit beta-1 Proteins 0.000 description 1
- 101001008558 Homo sapiens Laminin subunit beta-2 Proteins 0.000 description 1
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 description 1
- 101001020310 Homo sapiens Liprin-alpha-1 Proteins 0.000 description 1
- 101000942701 Homo sapiens Liprin-alpha-3 Proteins 0.000 description 1
- 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 description 1
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
- 101001090688 Homo sapiens Lymphocyte cytosolic protein 2 Proteins 0.000 description 1
- 101000624631 Homo sapiens M-phase inducer phosphatase 2 Proteins 0.000 description 1
- 101001134216 Homo sapiens Macrophage scavenger receptor types I and II Proteins 0.000 description 1
- 101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 description 1
- 101000577891 Homo sapiens Myeloid cell nuclear differentiation antigen Proteins 0.000 description 1
- 101000601047 Homo sapiens Nidogen-1 Proteins 0.000 description 1
- 101000622137 Homo sapiens P-selectin Proteins 0.000 description 1
- 101000986836 Homo sapiens P2Y purinoceptor 2 Proteins 0.000 description 1
- 101000693231 Homo sapiens PDZK1-interacting protein 1 Proteins 0.000 description 1
- 101000601664 Homo sapiens Paired box protein Pax-8 Proteins 0.000 description 1
- 101001136034 Homo sapiens Phosphoribosylformylglycinamidine synthase Proteins 0.000 description 1
- 101000583183 Homo sapiens Plakophilin-3 Proteins 0.000 description 1
- 101000609255 Homo sapiens Plasminogen activator inhibitor 1 Proteins 0.000 description 1
- 101000596041 Homo sapiens Plastin-1 Proteins 0.000 description 1
- 101001116302 Homo sapiens Platelet endothelial cell adhesion molecule Proteins 0.000 description 1
- 101000595198 Homo sapiens Podocalyxin Proteins 0.000 description 1
- 101001133932 Homo sapiens Prolyl 3-hydroxylase 3 Proteins 0.000 description 1
- 101000684208 Homo sapiens Prolyl endopeptidase FAP Proteins 0.000 description 1
- 101001057168 Homo sapiens Protein EVI2B Proteins 0.000 description 1
- 101001054867 Homo sapiens Protein-lysine 6-oxidase Proteins 0.000 description 1
- 101001131748 Homo sapiens Quinone oxidoreductase Proteins 0.000 description 1
- 101000848724 Homo sapiens Rap guanine nucleotide exchange factor 3 Proteins 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 101000606545 Homo sapiens Receptor-type tyrosine-protein phosphatase F Proteins 0.000 description 1
- 101001078087 Homo sapiens Reticulocalbin-2 Proteins 0.000 description 1
- 101000710013 Homo sapiens Reversion-inducing cysteine-rich protein with Kazal motifs Proteins 0.000 description 1
- 101001106406 Homo sapiens Rho GTPase-activating protein 1 Proteins 0.000 description 1
- 101001075558 Homo sapiens Rho GTPase-activating protein 29 Proteins 0.000 description 1
- 101000667821 Homo sapiens Rho-related GTP-binding protein RhoE Proteins 0.000 description 1
- 101000705806 Homo sapiens Riboflavin kinase Proteins 0.000 description 1
- 101000650814 Homo sapiens Semaphorin-4C Proteins 0.000 description 1
- 101000576901 Homo sapiens Serine/threonine-protein kinase MRCK alpha Proteins 0.000 description 1
- 101000869480 Homo sapiens Serum amyloid A-1 protein Proteins 0.000 description 1
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
- 101000881252 Homo sapiens Spectrin beta chain, non-erythrocytic 1 Proteins 0.000 description 1
- 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 description 1
- 101000796134 Homo sapiens Thymidine phosphorylase Proteins 0.000 description 1
- 101000634975 Homo sapiens Tripartite motif-containing protein 29 Proteins 0.000 description 1
- 101001087422 Homo sapiens Tyrosine-protein phosphatase non-receptor type 13 Proteins 0.000 description 1
- 101001135565 Homo sapiens Tyrosine-protein phosphatase non-receptor type 3 Proteins 0.000 description 1
- 101000742596 Homo sapiens Vascular endothelial growth factor C Proteins 0.000 description 1
- 101000621390 Homo sapiens Wee1-like protein kinase Proteins 0.000 description 1
- 101000744882 Homo sapiens Zinc finger protein 185 Proteins 0.000 description 1
- 101001049375 Homo sapiens eEF1A N-terminal methyltransferase Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100024035 Inositol 1,4,5-trisphosphate receptor type 3 Human genes 0.000 description 1
- 108010042918 Integrin alpha5beta1 Proteins 0.000 description 1
- 102100033011 Integrin beta-6 Human genes 0.000 description 1
- 102100033336 Integrin beta-8 Human genes 0.000 description 1
- 102000004551 Interleukin-10 Receptors Human genes 0.000 description 1
- 108010017550 Interleukin-10 Receptors Proteins 0.000 description 1
- 102100030236 Interleukin-10 receptor subunit alpha Human genes 0.000 description 1
- 102000003810 Interleukin-18 Human genes 0.000 description 1
- 108090000171 Interleukin-18 Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102100023974 Keratin, type II cytoskeletal 7 Human genes 0.000 description 1
- 108010066370 Keratin-20 Proteins 0.000 description 1
- 102100039020 Kunitz-type protease inhibitor 2 Human genes 0.000 description 1
- 102100033467 L-selectin Human genes 0.000 description 1
- 102100035113 LIM domain-binding protein 2 Human genes 0.000 description 1
- 102100030931 Ladinin-1 Human genes 0.000 description 1
- 102100022744 Laminin subunit alpha-3 Human genes 0.000 description 1
- 102100027450 Laminin subunit alpha-5 Human genes 0.000 description 1
- 102100027448 Laminin subunit beta-1 Human genes 0.000 description 1
- 102100024629 Laminin subunit beta-3 Human genes 0.000 description 1
- 102100035159 Laminin subunit gamma-2 Human genes 0.000 description 1
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 description 1
- 102100035684 Liprin-alpha-1 Human genes 0.000 description 1
- 102100032892 Liprin-alpha-3 Human genes 0.000 description 1
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 1
- 102100034709 Lymphocyte cytosolic protein 2 Human genes 0.000 description 1
- 102100023325 M-phase inducer phosphatase 2 Human genes 0.000 description 1
- 101150108610 MAL gene Proteins 0.000 description 1
- 102100034184 Macrophage scavenger receptor types I and II Human genes 0.000 description 1
- 108010024777 Mating Factor Receptors Proteins 0.000 description 1
- 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 102100030216 Matrix metalloproteinase-14 Human genes 0.000 description 1
- 101710151321 Melanostatin Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 description 1
- 206010027459 Metastases to lymph nodes Diseases 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000000562 Monocarboxylic Acid Transporters Human genes 0.000 description 1
- 108010041817 Monocarboxylic Acid Transporters Proteins 0.000 description 1
- 101000866339 Mus musculus Transcription factor E2F6 Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 206010028470 Mycoplasma infections Diseases 0.000 description 1
- 102100027994 Myeloid cell nuclear differentiation antigen Human genes 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 108010082739 NADPH Oxidase 2 Proteins 0.000 description 1
- 102100023210 Necdin Human genes 0.000 description 1
- 206010061309 Neoplasm progression Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 102400000064 Neuropeptide Y Human genes 0.000 description 1
- 102000005665 Neurotransmitter Transport Proteins Human genes 0.000 description 1
- 108010084810 Neurotransmitter Transport Proteins Proteins 0.000 description 1
- 102100036196 Nicotinate phosphoribosyltransferase Human genes 0.000 description 1
- 102100037369 Nidogen-1 Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 239000004218 Orcein Substances 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108060006580 PRAME Proteins 0.000 description 1
- 102000036673 PRAME Human genes 0.000 description 1
- 102100037502 Paired box protein Pax-8 Human genes 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 102100027184 Periplakin Human genes 0.000 description 1
- 101710202907 Periplakin Proteins 0.000 description 1
- 102100033118 Phosphatidate cytidylyltransferase 1 Human genes 0.000 description 1
- 101710178747 Phosphatidate cytidylyltransferase 1 Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108030004873 Phosphoribosylformylglycinamidine synthases Proteins 0.000 description 1
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 1
- 102100035181 Plastin-1 Human genes 0.000 description 1
- 102100036031 Podocalyxin Human genes 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
- 102100027249 Protein EVI2B Human genes 0.000 description 1
- 102100022309 Protein KIBRA Human genes 0.000 description 1
- 102100023097 Protein S100-A1 Human genes 0.000 description 1
- 101710145046 Protein kibra Proteins 0.000 description 1
- 102100026858 Protein-lysine 6-oxidase Human genes 0.000 description 1
- 108010010469 Qa-SNARE Proteins Proteins 0.000 description 1
- 102100034576 Quinone oxidoreductase Human genes 0.000 description 1
- 101150040459 RAS gene Proteins 0.000 description 1
- 101150076031 RAS1 gene Proteins 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 208000037323 Rare tumor Diseases 0.000 description 1
- 101100372762 Rattus norvegicus Flt1 gene Proteins 0.000 description 1
- 101000852966 Rattus norvegicus Interleukin-1 receptor-like 1 Proteins 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 1
- 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 description 1
- 102100039663 Receptor-type tyrosine-protein phosphatase F Human genes 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 102100025337 Reticulocalbin-2 Human genes 0.000 description 1
- 102100034634 Reversion-inducing cysteine-rich protein with Kazal motifs Human genes 0.000 description 1
- 102100021433 Rho GTPase-activating protein 1 Human genes 0.000 description 1
- 102100020899 Rho GTPase-activating protein 29 Human genes 0.000 description 1
- 102100039640 Rho-related GTP-binding protein RhoE Human genes 0.000 description 1
- 102100031289 Riboflavin kinase Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108010005173 SERPIN-B5 Proteins 0.000 description 1
- 108091006207 SLC-Transporter Proteins 0.000 description 1
- 102000037054 SLC-Transporter Human genes 0.000 description 1
- 108091006602 SLC16A5 Proteins 0.000 description 1
- 102000005019 SLC6A12 Human genes 0.000 description 1
- 108060007751 SLC6A12 Proteins 0.000 description 1
- 108091006248 SLC7 Cationic Amino Acid Transporter Proteins 0.000 description 1
- 108091006232 SLC7A5 Proteins 0.000 description 1
- 108010017324 STAT3 Transcription Factor Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101001092180 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RHO GTPase-activating protein RGD1 Proteins 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 102000011274 Secretoglobin Human genes 0.000 description 1
- 108050001520 Secretoglobin Proteins 0.000 description 1
- 102100027745 Semaphorin-4C Human genes 0.000 description 1
- 229940122055 Serine protease inhibitor Drugs 0.000 description 1
- 101710102218 Serine protease inhibitor Proteins 0.000 description 1
- 102100031462 Serine/threonine-protein kinase PLK2 Human genes 0.000 description 1
- 102100030333 Serpin B5 Human genes 0.000 description 1
- 102100032277 Serum amyloid A-1 protein Human genes 0.000 description 1
- 102100038081 Signal transducer CD24 Human genes 0.000 description 1
- 102100024040 Signal transducer and activator of transcription 3 Human genes 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 101100187186 Solanum lycopersicum LE16 gene Proteins 0.000 description 1
- 101100454441 Solanum lycopersicum LE25 gene Proteins 0.000 description 1
- 102100037612 Spectrin beta chain, non-erythrocytic 1 Human genes 0.000 description 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000019215 Supervillin Human genes 0.000 description 1
- 108050006606 Supervillin Proteins 0.000 description 1
- 102100038648 Synaptogyrin-3 Human genes 0.000 description 1
- 101710152208 Synaptogyrin-3 Proteins 0.000 description 1
- 102000050707 Syntaxin-11 Human genes 0.000 description 1
- 102000006467 TATA-Box Binding Protein Human genes 0.000 description 1
- 108010044281 TATA-Box Binding Protein Proteins 0.000 description 1
- 102100040296 TATA-box-binding protein Human genes 0.000 description 1
- 101150052863 THY1 gene Proteins 0.000 description 1
- 102100031372 Thymidine phosphorylase Human genes 0.000 description 1
- 102100026640 Tight junction protein ZO-3 Human genes 0.000 description 1
- 108050001377 Tight junction protein ZO-3 Proteins 0.000 description 1
- 108010031372 Tissue Inhibitor of Metalloproteinase-2 Proteins 0.000 description 1
- 102100032120 Toll/interleukin-1 receptor domain-containing adapter protein Human genes 0.000 description 1
- 102100029519 Tripartite motif-containing protein 29 Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- 102100040959 Tyrosine-protein kinase FRK Human genes 0.000 description 1
- 102100033014 Tyrosine-protein phosphatase non-receptor type 13 Human genes 0.000 description 1
- 102100033131 Tyrosine-protein phosphatase non-receptor type 3 Human genes 0.000 description 1
- 101710172645 UDP-glycosyltransferase 2 Proteins 0.000 description 1
- 108091008605 VEGF receptors Proteins 0.000 description 1
- 108010073923 Vascular Endothelial Growth Factor C Proteins 0.000 description 1
- 102000009520 Vascular Endothelial Growth Factor C Human genes 0.000 description 1
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 description 1
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 1
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 1
- 102100038232 Vascular endothelial growth factor C Human genes 0.000 description 1
- 208000014070 Vestibular schwannoma Diseases 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 101150040313 Wee1 gene Proteins 0.000 description 1
- 102100023037 Wee1-like protein kinase Human genes 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 108010023606 Zinc Finger E-box-Binding Homeobox 1 Proteins 0.000 description 1
- 102100040814 Zinc finger protein 165 Human genes 0.000 description 1
- 101710145512 Zinc finger protein 165 Proteins 0.000 description 1
- 102100040032 Zinc finger protein 185 Human genes 0.000 description 1
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 description 1
- 208000004064 acoustic neuroma Diseases 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 231100001075 aneuploidy Toxicity 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000005975 antitumor immune response Effects 0.000 description 1
- 229940114078 arachidonate Drugs 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000003363 arteriovenous anastomosis Anatomy 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000003339 best practice Methods 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 238000000339 bright-field microscopy Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940022399 cancer vaccine Drugs 0.000 description 1
- 230000005773 cancer-related death Effects 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000003306 cell dissemination Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004709 cell invasion Effects 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000013043 cell viability test Methods 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- 230000007960 cellular response to stress Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 210000003040 circulating cell Anatomy 0.000 description 1
- 210000002358 circulating endothelial cell Anatomy 0.000 description 1
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 108010009442 cytochrome b245 Proteins 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000007435 diagnostic evaluation Methods 0.000 description 1
- 229940124466 diagnostic for cancer Drugs 0.000 description 1
- 238000001085 differential centrifugation Methods 0.000 description 1
- 230000009274 differential gene expression Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 102000013035 dynein heavy chain Human genes 0.000 description 1
- 108060002430 dynein heavy chain Proteins 0.000 description 1
- 102100023730 eEF1A N-terminal methyltransferase Human genes 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000002449 erythroblastic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011124 ex vivo culture Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 206010016629 fibroma Diseases 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000001650 focal adhesion Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 102000040409 glycosyltransferase 2 family Human genes 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 210000004524 haematopoietic cell Anatomy 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 238000012759 hoechst 33342 nuclear staining Methods 0.000 description 1
- 102000051318 human LOX Human genes 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000030776 invasive breast carcinoma Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 108010028309 kalinin Proteins 0.000 description 1
- 238000000370 laser capture micro-dissection Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 108091005446 macrophage receptors Proteins 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000009607 mammography Methods 0.000 description 1
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 description 1
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 238000001531 micro-dissection Methods 0.000 description 1
- 210000001724 microfibril Anatomy 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000000491 multivariate analysis Methods 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000023362 neuron cell-cell adhesion Effects 0.000 description 1
- 210000004882 non-tumor cell Anatomy 0.000 description 1
- 210000002261 nucleate cell Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 208000013371 ovarian adenocarcinoma Diseases 0.000 description 1
- 208000012988 ovarian serous adenocarcinoma Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- 208000023958 prostate neoplasm Diseases 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003751 purification from natural source Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 108700042226 ras Genes Proteins 0.000 description 1
- 108010014186 ras Proteins Proteins 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000019309 regulation of fibroblast migration Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 108010047833 sarcolectin Proteins 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 108010017797 serum-inducible kinase Proteins 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000010304 tumor cell viability Effects 0.000 description 1
- 230000005751 tumor progression Effects 0.000 description 1
- 231100000588 tumorigenic Toxicity 0.000 description 1
- 230000000381 tumorigenic effect Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229960001134 von willebrand factor Drugs 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5082—Test tubes per se
- B01L3/50825—Closing or opening means, corks, bungs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0093—Purging against cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/046—Function or devices integrated in the closure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Sustainable Development (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51657103P | 2003-10-31 | 2003-10-31 | |
US60/516,571 | 2003-10-31 | ||
PCT/US2004/036177 WO2005043121A2 (en) | 2003-10-31 | 2004-10-30 | Blood test prototypes and methods for the detection of circulating tumor and endothelial cells |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2544373A1 true CA2544373A1 (en) | 2005-05-12 |
Family
ID=34549552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002544373A Abandoned CA2544373A1 (en) | 2003-10-31 | 2004-10-30 | Blood test prototypes and methods for the detection of circulating tumor and endothelial cells |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1706720A4 (de) |
JP (1) | JP2007526761A (de) |
CN (2) | CN1922304A (de) |
AU (1) | AU2004286307A1 (de) |
CA (1) | CA2544373A1 (de) |
HK (1) | HK1209778A1 (de) |
WO (1) | WO2005043121A2 (de) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6913697B2 (en) | 2001-02-14 | 2005-07-05 | Science & Technology Corporation @ Unm | Nanostructured separation and analysis devices for biological membranes |
US8895298B2 (en) | 2002-09-27 | 2014-11-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
WO2006031524A2 (en) | 2004-09-10 | 2006-03-23 | The Regents Of The Unversity Of Colorado | Early detection of hemangiosarcoma and angiosarcoma |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US7769547B2 (en) * | 2005-11-01 | 2010-08-03 | David S. Alberts | Karyometry-based method for prediction of cancer event recurrence |
WO2007121464A2 (en) * | 2006-04-18 | 2007-10-25 | Wellstat Biologics Corporation | Detection of circulating endothelial cells |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
EP1867995A1 (de) * | 2006-06-15 | 2007-12-19 | Cézanne S.A.S. | In-vitro-Verfahren zur Diagnose und Überwachung von metastasiertem Blasenkrebs durch Verwendung der MMP-7-Bestimmung im Blutkreislauf von Patienten |
BRPI0820793A2 (pt) | 2007-12-10 | 2015-06-16 | Hoffmann La Roche | Seprase como marcador de câncer |
PT2334812T (pt) | 2008-09-20 | 2017-03-29 | Univ Leland Stanford Junior | ¿diagnóstico não invasivo de aneuploidia fetal por sequenciação |
ITCZ20090001A1 (it) * | 2009-01-13 | 2010-07-14 | Natalia Malara | Isolamento e messa in coltura di cellule epiteliali tumorali dal sangue e dai suoi derivati in pazienti affetti da cancro epiteliale solido |
EP2363501A1 (de) * | 2010-03-02 | 2011-09-07 | Universitätsklinikum Hamburg-Eppendorf | Verfahren zur Isolierung von Zielzellen |
CN102213722B (zh) * | 2010-04-06 | 2014-03-12 | 北京蛋白质组研究中心 | 一种检测蛋白表达水平的试剂盒在制备诊断肝细胞癌的试剂盒中的应用 |
EP2593787B1 (de) | 2010-07-16 | 2018-07-04 | Stichting VUmc | Verfahren zur analyse einer blutprobe auf das vorhandensein eines krankeits-markers |
US10174365B2 (en) | 2011-03-18 | 2019-01-08 | Stichting Vu-Vumc | Method of analysing a blood sample of a subject for the presence of a disease marker |
CA2839313C (en) | 2011-06-13 | 2018-03-13 | Hitachi Chemical Company, Ltd. | Agent for improving cancer cell adhesiveness |
CN103782170A (zh) * | 2011-07-07 | 2014-05-07 | 斯克里普斯健康机构 | 分析心血管病症的方法及其用途 |
JP6054389B2 (ja) * | 2011-07-08 | 2016-12-27 | スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ | 標識されたhsp90阻害剤の使用 |
JP5834559B2 (ja) * | 2011-07-12 | 2015-12-24 | コニカミノルタ株式会社 | 目的細胞の検査方法 |
JP6208473B2 (ja) | 2012-06-20 | 2017-10-04 | アークレイ株式会社 | 血液成分を含む試料の処理方法 |
WO2014072465A1 (en) * | 2012-11-09 | 2014-05-15 | Roche Diagnostics Gmbh | In vitro capture and analysis of circulating tumor cells |
CN105122031B (zh) * | 2012-11-20 | 2019-02-01 | 纽约哥伦比亚大学董事会 | 医疗设备以及用于收集生物样本的方法 |
US10161939B2 (en) | 2013-02-02 | 2018-12-25 | Duke University | Method of isolating circulating tumor cells |
KR101922322B1 (ko) * | 2014-07-22 | 2018-11-26 | 가부시키가이샤 간멘에키켄큐쇼 | 말초 순환 암세포의 검출 방법 및 검출 장치 |
JP6693966B2 (ja) * | 2015-01-21 | 2020-05-13 | エージェンシー フォー サイエンス, テクノロジー アンド リサーチ | サイズに基づいて希少細胞を回収するためのカラムベースのデバイスおよび方法ならびにその使用 |
JP6901253B2 (ja) * | 2015-10-21 | 2021-07-14 | 株式会社日本触媒 | 接着性細胞培養用基材、ならびにこれを利用した細胞培養容器および細胞培養方法 |
CN105420088B (zh) * | 2015-11-11 | 2017-12-29 | 深圳市达科为生物工程有限公司 | 一种细胞分离管 |
KR20170070839A (ko) * | 2015-12-14 | 2017-06-22 | 주식회사 퀀타매트릭스 | 이종 세포들의 혼합물로부터 특정 세포를 구별하는 방법 |
JP6518985B2 (ja) * | 2016-09-29 | 2019-05-29 | 住友ゴム工業株式会社 | がん細胞捕捉方法 |
SG11201901782TA (en) * | 2016-11-02 | 2019-05-30 | Emd Millipore Corp | Container for separating microcarriers from cell culture fluids |
AU2017379367B2 (en) * | 2016-12-20 | 2023-12-07 | Sangui Bio Pty. Ltd | Blood profiling with protease inhibitors |
CN108220233B (zh) * | 2016-12-21 | 2021-07-09 | 上海透景诊断科技有限公司 | 细胞分离器具表面处理方法、相关器具、外周血稀有细胞或循环肿瘤细胞快速高效分离方法 |
EP3342485B1 (de) * | 2017-01-02 | 2020-07-08 | Thinxxs Microtechnology Ag | Halterung für reagenzträgerelemente |
CN106754650B (zh) * | 2017-02-24 | 2018-10-02 | 哈尔滨中科赛恩斯生物技术有限公司 | 一种骨髓来源的内皮祖细胞培养方法 |
CN106840816A (zh) * | 2017-03-14 | 2017-06-13 | 骏实生物科技(上海)有限公司 | 一种全自动循环肿瘤细胞阴性富集装置 |
JP7278595B2 (ja) * | 2017-03-16 | 2023-05-22 | ユニベルシテ リブレ デ ブリュッセル | Cd321マーカーの発現に基づく循環腫瘍細胞の検出、定量化、及び/又は単離 |
EP3662052A4 (de) * | 2017-08-02 | 2021-03-24 | Hemosmart MedicalTechnology Ltd. | Funktionalisiertes netz und fluidische vorrichtung zum einfangen von zellen oder molekülen in lösung |
US11525829B2 (en) * | 2017-08-02 | 2022-12-13 | Hemosmart Medical Technology Ltd. | Method for capturing target cells or molecules in solution |
CN108031614B (zh) * | 2017-12-14 | 2020-04-17 | 四川福德机器人股份有限公司 | 一种燃气表的涂胶自动补偿方法及采用该方法的装置 |
WO2019185874A1 (en) * | 2018-03-30 | 2019-10-03 | Exosomics S.p.A. | Use of hollow fibers to obtain blood or a blood derivative impoverished from blood cells and platelets derived extracellular vesicles |
CN109294973A (zh) * | 2018-10-18 | 2019-02-01 | 重庆医科大学 | 一种基于磁珠法阴性去除血尿白细胞富集上皮细胞的方法 |
CN109887542A (zh) * | 2019-02-12 | 2019-06-14 | 嘉兴海云惠智医疗科技有限公司 | 一种基于云计算的肿瘤个体化基因检测智能解读系统 |
CN111751543A (zh) * | 2019-03-27 | 2020-10-09 | 南方医科大学南方医院 | 一种稀有肿瘤细胞富集方法及试剂盒 |
JP6886667B2 (ja) * | 2019-03-27 | 2021-06-16 | 住友ゴム工業株式会社 | がん細胞捕捉方法 |
CN111235021B (zh) * | 2020-03-06 | 2022-09-27 | 大连海事大学 | 一种双液相外周血中循环肿瘤细胞分离与检测装置及方法 |
CN112255408B (zh) * | 2020-10-16 | 2023-04-14 | 牡丹江医学院 | 一种肿瘤生物标志物及肿瘤检测试剂盒 |
CN113117359B (zh) * | 2021-03-05 | 2022-08-26 | 湘雅生物医药(湖州)有限公司 | 一种用于胶原蛋白提取用的无菌式蒸馏瓶 |
CN113049344B (zh) * | 2021-04-20 | 2022-02-01 | 深圳天烁生物科技有限公司 | 细胞染色的质控品制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4092246A (en) * | 1975-05-16 | 1978-05-30 | Abcor, Inc. | Helically wound blood filter |
US4829000A (en) * | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
US5147797A (en) * | 1987-08-25 | 1992-09-15 | Regents Of The University Of Minnesota | Polypeptides with fibronectin activity |
WO1996009876A1 (en) * | 1992-09-11 | 1996-04-04 | Xenogenex, Inc. | Artificial liver apparatus and method |
FI93742C (fi) * | 1992-10-23 | 1995-05-26 | Elias Hakalehto | Menetelmä ja laite solujen osoittamiseksi |
ATE237676T1 (de) * | 1995-02-16 | 2003-05-15 | Forschungszentrum Juelich Gmbh | Verfahren zur kultivierung von organfunktionszellen |
US5840514A (en) * | 1996-11-21 | 1998-11-24 | The Regents Of The University Of Michigan | Methods of testing cancer and anticancer drugs |
GB9704444D0 (en) * | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
JPH11127843A (ja) * | 1997-10-27 | 1999-05-18 | Sumitomo Bakelite Co Ltd | 培養用着色容器 |
US6060317A (en) * | 1998-08-11 | 2000-05-09 | The United States Of America As Represented By The Department Of Health And Human Services | Method of transducing mammalian cells, and products related thereto |
WO2000015665A2 (en) * | 1998-09-14 | 2000-03-23 | Pedersen Lars Oestergaard | A method of producing a functional immunoglobulin superfamily protein |
EP1315829B1 (de) * | 2000-09-09 | 2010-07-28 | The Research Foundation Of State University Of New York | Verfahren und zusammensetzungen zur isolierung von metastatischen krebszellen und anwendung zur messung des metastatischen potentials eines krebses |
GB0025245D0 (en) * | 2000-10-14 | 2000-11-29 | Lee Helen | Multiple target detection |
CN1118563C (zh) * | 2000-12-08 | 2003-08-20 | 中国医学科学院血液学研究所 | 中空纤维模拟骨髓造血装置 |
WO2003035888A1 (en) * | 2001-08-28 | 2003-05-01 | Wen-Tien Chen | Cell separation matrix |
ES2284927T3 (es) * | 2001-09-06 | 2007-11-16 | Adnagen Ag | Procedimiento y kit para el diagnostico o el control del tratamiento del cancer. |
-
2004
- 2004-10-30 CN CNA2004800393630A patent/CN1922304A/zh active Pending
- 2004-10-30 EP EP04796843A patent/EP1706720A4/de not_active Withdrawn
- 2004-10-30 CN CN201410710695.2A patent/CN104531529A/zh active Pending
- 2004-10-30 AU AU2004286307A patent/AU2004286307A1/en not_active Abandoned
- 2004-10-30 JP JP2006538370A patent/JP2007526761A/ja active Pending
- 2004-10-30 WO PCT/US2004/036177 patent/WO2005043121A2/en active Application Filing
- 2004-10-30 CA CA002544373A patent/CA2544373A1/en not_active Abandoned
-
2015
- 2015-10-22 HK HK15110407.9A patent/HK1209778A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN1922304A (zh) | 2007-02-28 |
AU2004286307A1 (en) | 2005-05-12 |
EP1706720A2 (de) | 2006-10-04 |
EP1706720A4 (de) | 2007-02-28 |
JP2007526761A (ja) | 2007-09-20 |
HK1209778A1 (en) | 2016-04-08 |
WO2005043121A2 (en) | 2005-05-12 |
WO2005043121A3 (en) | 2006-08-24 |
CN104531529A (zh) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2544373A1 (en) | Blood test prototypes and methods for the detection of circulating tumor and endothelial cells | |
US20050244843A1 (en) | Blood test prototypes and methods for the detection of circulating tumor and endothelial cells | |
Tan et al. | Microdevice for the isolation and enumeration of cancer cells from blood | |
Jiang et al. | Microfluidic isolation of platelet-covered circulating tumor cells | |
DK2542689T3 (en) | Method for isolating target cells | |
US20050272103A1 (en) | Cell separation matrix | |
JP6637484B2 (ja) | 血小板を標的とするマイクロ流体細胞単離 | |
Morgan et al. | Detection and characterization of circulating and disseminated prostate cancer cells | |
Zhang et al. | Micrometastasis in gastric cancer | |
US5648222A (en) | Method for preserving cells, and uses of said method | |
US20170234851A1 (en) | Methods and Apparatus for Segregation of Particles | |
US20130337500A1 (en) | System and method for isolation of cells | |
WO2019214063A1 (zh) | 一种循环肿瘤细胞的检测方法 | |
Au et al. | Clusters of circulating tumor cells: a biophysical and technological perspective | |
JP2008529541A (ja) | 腫瘍細胞の分離用容器 | |
MX2012006244A (es) | Metodos y aparatos para segregacion de particulas, incluyendo segregacion y proliferacion de celulas fetales y celulas madre. | |
US6998234B2 (en) | Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells | |
Stefansson et al. | A cell transportation solution that preserves live circulating tumor cells in patient blood samples | |
JP7306618B2 (ja) | がんの転移形成能に関与する因子および前記因子を用いたがん患者の予後予測方法 | |
US20060057650A1 (en) | Method for the immunocytological or molecular detection of disseminated tumor cells from a body fluid and kit that is suitable therefor | |
AU2016395556B2 (en) | Method for detecting or separating/obtaining circulating tumor cell employing cell proliferation method | |
Jiménez‐Zenteno et al. | Liquid Biopsy Based on Circulating Cancer‐Associated Cells: Bridging the Gap from an Emerging Concept to a Mainstream Tool in Precision Medicine | |
WO2003035888A1 (en) | Cell separation matrix | |
Murlidhar | Capture and Characterization of Circulating Tumor Cells (CTCs) in Early Lung Cancer Using a Novel High-throughput Affinity-based Microfluidic Device. | |
CN112946270A (zh) | 用于诊断体内恶性实体肿瘤的方法和试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |